Hepatitis C Treatment Naive Genotype 1 Consensus Interferon Trial

NCT00211692 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

64

Enrollment

FED

Sponsor class

Conditions

Chronic Hepatitis C

Interventions

DRUG: consensus interferon (Interferon Alfacon-1) and ribavirin
DRUG: Consensus Interferon alfa (CIFN) and ribavirin

Sponsor

Minneapolis Veterans Affairs Medical Center

Collaborators

[object Object]
[object Object]
[object Object]
[object Object]
[object Object]